$MGRM News

Last published 1y ago

1y agoZBH MGRMZimmer Biomet Announces Second Quarter 2025 Financial ResultsPR NewswireZimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended June 30, 2025. The Company reported second...
1y agoMGRMMonogram Technologies Announces World's First Fully Autonomous Saw-Based Robotic Knee Replacement SurgeryGlobeNewswireThe Procedure Utilized Monogram's mBôs TKA System Performed in India with Shalby Hospitals Groundbreaking Procedure Delivers the World's First Autonomous Saw-Based Robotic TKA Surgery on a Live Patient
1y agoAGEN CLOV ZBH MGRMFrom Diagnosis to Surgery: How AI Tech Is Quietly Reshaping Healthcare ProfitsPR NewswireUSA News Group News Commentary – The AI revolution in healthcare is fully underway, with the potential to save lives and money, but there's still...
1y agoMGRMMGRM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Monogram Technologies to Zimmer BiometGlobeNewswireMONSEY, N.Y., July 14, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Monogram Technologies, Inc. (NASDAQ:MGRM) ("Monogram") to Zimmer Biomet for
1y agoMGRMZimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous SolutionsGlobeNewswireProposed transaction creates the broadest, most flexible portfolio of orthopedic robotics and navigation technologies to meet surgeons' needs Acquisition expected to be neutral to adjusted earnings per share in 2025 –
1y agoZBH MGRMZimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous SolutionsPR NewswireZimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Monogram Technologies Inc. (NASDAQ: MGRM), an orthopedic...
1y agoMGRMMonogram Technologies Announces the Mandatory Conversion of 8.00% Series D Convertible Cumulative Preferred StockACCESS NewswireAUSTIN, TEXAS / ACCESS Newswire / July 8, 2025 / Monogram Technologies Inc. , an AI-driven robotics company revolutionizing orthopedic surgery, today
1y agoMGRMMonogram Technologies Reports First Quarter 2025 Financial ResultsGlobeNewswireReceives FDA Clearance for the mBôs™ TKA System Groundbreaking Trial Set to Deliver one of the World's First Autonomous Saw-Based Robotic TKA Surgeries on Live Patients Management to Host Business Update
1y agoMGRMMonogram Technologies to Host First Quarter 2025 Results Conference Call on Wednesday, May 14, 2025 at 4:30 p.m. Eastern TimeACCESS NewswireAUSTIN, TX / ACCESS Newswire / May 6, 2025 / Monogram Technologies Inc. , an AI-driven robotics company revolutionizing orthopedic surgery, will hold a
1y agoMGRMCORRECTION FROM SOURCE: Monogram Technologies Receives Regulatory Approval to Start Clinical Trials in IndiaACCESS NewswireMonogram Granted Regulatory Approval to Import mBôs TKA System for Clinical InvestigationPatient Enrollment will Begin Shortly; First Live Patient Surgeries are Anticipated within 90 Business DaysCritical Milestone
1y agoMGRMMonogram Technologies Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation in IndiaACCESS NewswirePatient Enrollment will Begin Shortly; First Live Patient Surgeries are Anticipated within 90 Business DaysCritical Milestone Achieved for Multi-Center Clinical Trial in India with Strategic Partner Shalby Hospitals for
1y agoMGRMMonogram Technologies Partners with Urvin to Launch an Exclusive, Verified Shareholder CommunityACCESS NewswireAUSTIN, TX / ACCESS Newswire / March 20, 2025 / Monogram Technologies Inc. , an AI-driven robotics company focused on improving human health with an initial
1y agoMGRMMonogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA SystemACCESS NewswireMonogram May Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act .The Company is Preparing for Commercialization and Evaluating Strategies to
1y agoMGRMCORRECTION: Monogram Technologies Reports Full Year 2024 Financial ResultsACCESS NewswireThis Press Release is Acting as a Correction to the Financial Tables in the Previous ReleaseCompleted all Supplemental Testing and has Submitted its Formal Response to the FDA's Additional Information Request
1y agoMGRMMonogram Technologies Reports Full Year 2024 Financial ResultsACCESS NewswireCompleted all Supplemental Testing and has Submitted its Formal Response to the FDA's Additional Information Request Management to Host Business Update Conference Call on Wednesday, March 12, 2025, at 4:30 p.m.
1y agoMGRMMonogram Technologies to Participate in the 37th Annual ROTH Conference in California March 16-18, 2025ACCESS NewswireAUSTIN, TX / ACCESS Newswire / March 5, 2025 / Monogram Technologies Inc. , an AI-driven robotics company focused on improving human health with an initial
1y agoMGRMMonogram Technologies to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday, March 12, 2025 at 4:30 p.m. Eastern TimeACCESS NewswireAUSTIN, TX / ACCESS Newswire / February 27, 2025 / Monogram Technologies Inc. , an AI-driven robotics company focused on improving human health with an
1y agoMGRMMonogram Technologies Provides Regulatory Update on mBôs TKA System and Clinical Trial Preparation in IndiaACCESS NewswireCompany has Completed all Supplemental Testing and has Submitted its Formal Response to the FDA's Additional Information Request Investigator Meeting and Clinical Trial Training Held at the Shalby Hospital in
1y agoMGRMMonogram Technologies Provides 510(k) Submission Update Following Positive Meeting with FDAACCESS NewswireManagement Anticipates That it has Sufficiently Addressed the FDA's Concerns to Mitigate the Need for a Clinical Data RequestManagement Anticipates a Comprehensive AIR Response in Q1 2025 AUSTIN, TEXAS / ACCESSWIRE /
1y agoMGRMMonogram Technologies Announces Management and Related Parties Complete Open Market Purchases of MGRM Common Stock Totaling $1 MillionACCESS NewswireAUSTIN, TEXAS / ACCESSWIRE / December 2, 2024 / Monogram Technologies Inc. , an AI-driven robotics company focused on improving human health with an initial
1y agoMGRMMonogram Technologies Inc. (MGRM) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
1y agoMGRMMonogram Technologies Reports Third Quarter 2024 Financial ResultsACCESS NewswireClosed an Upsized and Oversubscribed $13 Million Public Offering to Fund Near-term Commercialization MilestonesManagement to Host Business Update Conference Call on Tuesday, November 19, 2024 at 4:30 p.m. Eastern Time
1y agoMGRMMonogram Technologies to Host Third Quarter 2024 Results Conference Call on Tuesday, November 19, 2024 at 4:30 p.m. Eastern TimeACCESS NewswireAUSTIN, TX / ACCESSWIRE / November 12, 2024 / Monogram Technologies Inc. , an AI-driven robotics company focused on improving human health with an initial
2y agoMGRMMonogram Technologies Named Orthopedic Joint Replacement Company of the Year 2024ACCESS NewswireAward from Medical Tech Outlook Highlights Monogram's mBôs TKA System AUSTIN, TX / ACCESSWIRE / October 29, 2024 / Monogram Technologies Inc. , an
2y agoMGRMMonogram Technologies to Present at the LD Micro Main Event XVII Conference on Wednesday October 30, 2024ACCESS NewswireAUSTIN, TX / ACCESSWIRE / October 16, 2024 / Monogram Technologies Inc. , an AI-driven robotics company focused on improving human health with an initial
2y agoMGRMCORRECTION FROM SOURCE: Monogram Technologies Issues Correction to Press Release Announcing it Received an FDA Response for its mBôs TKA SystemACCESS NewswireCompany Has 180 Days From Receipt to Produce Additional InformationAUSTIN, TX / ACCESSWIRE / October 3, 2024 / Monogram Technologies Inc. , an AI-driven
2y agoMGRMMonogram Technologies Receives FDA Response for mBôs TKA SystemACCESS NewswireCompany to Conduct Clinical Trial to Produce Additional Information Within 180 DaysAUSTIN, TX / ACCESSWIRE / October 2, 2024 / Monogram Technologies Inc. ,
2y agoMGRMMonogram Technologies Announces Closing of Upsized and Oversubscribed $13 Million Public OfferingACCESS NewswireAUSTIN, TX / ACCESSWIRE / October 2, 2024 / Monogram Technologies Inc. , an AI-driven robotics company focused on improving human health with an initial
2y agoMGRMMonogram Technologies Announces Preferred Stock DividendsACCESS NewswireAUSTIN, TX / ACCESSWIRE / October 1, 2024 / Monogram Technologies Inc. , an AI-driven robotics company focused on improving human health with an initial
2y agoMGRMMonogram Technologies Upsizes 8.00% Series D Convertible Cumulative Preferred Stock and Warrant Offering to $12.5 MillionACCESS NewswireAUSTIN, TX / ACCESSWIRE / September 11, 2024 / Monogram Technologies Inc. , an AI-driven robotics company focused on improving human health with an initial
2y agoMGRMMonogram Technologies Inc. (MGRM) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoMGRMMonogram Technologies Reports Second Quarter 2024 Financial ResultsACCESS NewswireSubmitted FDA 510 Application and Passed FDA Administrative Review for the mBôs TKA SystemSecured Initial Strategic Multicenter Clinical Trial Collaboration with Shalby LimitedManagement to Host Business Update
2y agoMGRMMonogram Technologies Secures Initial Strategic Clinical Trial CollaborationACCESS NewswireClinical Trial Collaboration Follows 510 Submission and Passing of FDA Administrative Review; Preludes Planned International Launch for the mBȏs TKA SystemStrategic Partner Shalby is Recognized as one of the Leading
2y agoMGRMMonogram Technologies Submits 510(k) Application for mBôs TKA System ClearanceACCESS NewswireApplication was Submitted on July 19, 2024, Passed the FDA Administrative Review, and is Now Under Substantive ReviewFDA Decision is Expected Within 90 Days of Initial Submission; However, the Process May be Paused if
2y agoMGRMMonogram Technologies to Host Second Quarter 2024 Business Update Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern TimeACCESS NewswireAUSTIN, TX / ACCESSWIRE / August 1, 2024 / Monogram Technologies Inc. , an AI-driven robotics company focused on improving human health with an initial focus
2y agoMGRMMonogram Technologies Launches Continuous Offering of 8.00% Convertible Preferred Stock and WarrantsACCESS NewswireAUSTIN, TX / ACCESSWIRE / July 9, 2024 / Monogram Technologies Inc. , an AI-driven robotics company focused on improving human health with an initial focus
2y agoMGRMMonogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June 20th, 2024ACCESS NewswireManagement to Showcase Product Demonstration of mBôs Precision Robotic Surgical System and mVision Technologies AUSTIN, TX / ACCESSWIRE / June 3, 2024 / Monogram Technologies Inc. ("Monogram"
2y agoMGRMMonogram Technologies Inc. (MGRM) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoMGRMMonogram Orthopaedics Completes Corporate Name Change to Monogram TechnologiesACCESS NewswireNew Name Reflects Continued Evolution as an AI-Driven Robotics Company with a Strong IP Position AUSTIN, TX / ACCESSWIRE / May 15, 2024 / Monogram Orthopaedics Inc. ("Monogram" or the
2y agoMGRMMonogram Orthopaedics Reports First Quarter 2024 Financial ResultsACCESS NewswireVerification and Validation Testing Expected to be Largely Complete in Q2 2024; 510 Submission with FDA Accelerated for Second Half of 2024Engaged Contract Research Organization to Oversee mBôs Robot Clinical
2y agoMGRMMonogram Engages Contract Research Organization to Oversee mBôs Robot Clinical Trial Activities Outside the U.S.ACCESS NewswireCRO Expands Clinical Capabilities, Accelerating Product Pipeline Development and Commercialization Opportunities AUSTIN, TX / ACCESSWIRE / May 13, 2024 / Monogram Orthopaedics Inc. ("Monogram" or
2y agoMGRMMonogram Accepted to NVIDIA Inception ProgramACCESS NewswireCollaboration to Provide Monogram with Technical Resources to Drive Development and Commercialization of mBôs SystemAUSTIN, TX / ACCESSWIRE / April 11, 2024 / Monogram Orthopaedics Inc.
2y agoMGRMMonogram Orthopaedics, Inc. (MGRM) Q4 2023 Earnings Call TranscriptEarnings Call Transcripts
2y agoMGRMMonogram Orthopaedics to Host Business Update Conference Call on Thursday, March 21st at 5:00 p.m. Eastern TimeACCESS NewswireAUSTIN, TX / ACCESSWIRE / March 20, 2024 / Monogram Orthopaedics Inc. , a medical technology company focused on reconstructive joint procedures and surgical
2y agoMGRMMonogram Orthopaedics Reports Full Year 2023 Financial ResultsACCESS Newswire510 Submission with FDA On Track for Second Half of 2024Shipped mBôs Surgical Robot System to First International CustomerIntroduced mVision Technologies, a Novel Approach to Registration and TrackingManagement
2y agoMGRMMonogram Orthopaedics to Present Rescheduled Product Discussion with Surgeon Reaction during AAOS Annual MeetingACCESS NewswireEvent features Monogram's mBôs commercial robot alongside panel of orthopaedic surgeonsAUSTIN, TX / ACCESSWIRE / February 12, 2024 / Monogram Orthopaedics Inc. ("Monogram" or the
2y agoMGRMMonogram Orthopaedics to Present at the Canaccord Genuity Musculoskeletal Conference on February 12, 2024ACCESS NewswireAUSTIN, TX / ACCESSWIRE / January 24, 2024 / Monogram Orthopaedics Inc. , a medical technology company focused on reconstructive joint procedures and
2y agoMGRMMonogram Orthopaedics to Reschedule Robotic Product Demo Live StreamACCESS NewswireAUSTIN, TX / ACCESSWIRE / December 14, 2023 / Monogram Orthopaedics Inc. , a medical technology company focused on reconstructive joint procedures and
2y agoMGRMMonogram Orthopaedics to Host Robotic Product Demo Live Stream on Thursday, December 14, 2023 at 11:00 a.m. Eastern TimeACCESS Newswire- Demo will feature Monogram's mBôs commercial robot with teaser -AUSTIN, TX / ACCESSWIRE / November 30, 2023 / Monogram Orthopaedics Inc. , a medical
2y agoMGRMMonogram Orthopaedics Delivers First Surgical RobotACCESS Newswire- First Sale to Major Global Distributor Represents Key Revenue Milestone and Paves the Way for Broader Commercialization -AUSTIN, TX / ACCESSWIRE / November 28, 2023 / Monogram Orthopaedics Inc.